z-logo
Premium
Marginal parent donors—Process and ethics
Author(s) -
Filler Guido,
Ferris Maria E. DiazGonzalez,
Elliott Launa
Publication year - 2021
Publication title -
pediatric transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 69
eISSN - 1399-3046
pISSN - 1397-3142
DOI - 10.1111/petr.14062
Subject(s) - beneficence , medicine , harm , autonomy , donation , economic justice , transplantation , respect for persons , health care , nursing , intensive care medicine , social psychology , psychology , surgery , law , political science
Background Pre‐emptive kidney transplantation for end‐stage kidney disease in children has many advantages and may lead to the consideration of marginal parent donors. Methods Using the example of the transplant of a kidney with medullary sponge disease from a parent to the child, we review the ethical framework for working up such donors. Results The four principles of health ethics include autonomy (the right of the patient to retain control over his/her own body); beneficence (healthcare providers must do all they can do to benefit the patient in each situation); non‐maleficence (“first do no harm”—providers must consider whether other people or society could be harmed by a decision made, even if it is made for the benefit of an individual patient) and justice (there should be an element of fairness in all medical decisions). Highly motivated donors may derive significant psychological benefit from their donation and may thus be willing to incur more risk. The transplantation team and, ideally, an independent donor advocate team must make a judgment about the acceptability of the risk‐benefit ratio for particular potential donors, who must also make their own assessment. The transplantation team and donor advocate team must be comfortable with the risk‐benefit ratio before proceeding. Conclusions An independent donor advocacy team that focuses on the donor needs is needed with sufficient multidisciplinary ethical, social, and psychological expertise. The decision to accept or reject the donor should be within the authority of the independent donor advocacy team and not the providers or the donor.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here